-
Closing plenary to explore the future of CAR T-cell therapy in solid tumors
Presentations on promising clinical trial results with CAR T-cell therapies in a variety of solid tumors will close out the 2025 Tandem Meetings. Marcela Maus, MD, PhD, previews the new cell therapies to be discussed.
-
Authors highlight groundbreaking science with Best Abstracts
Best Abstract presentations shared key research insights and findings.
-
Session examines post-HCT relapse in AML
Vanessa Kennedy, MD, and other experts detailed novel targets, next-gen transplantation techniques and more.
-
Plenary provides update on allogeneic hematopoietic cell graft engineering
Scientific Organizing Committee chairs, Marie Bleakley, MD, PhD, MMsc, and Melody Smith, MD, MS, and others explain new strategies targeting recurrent hematological malignancies and GVHD.
-
Experts discuss metagenomic next-generation sequencing in TID
Yeon Joo Lee, MD, MPH, and other panelists presented cases that highlighted the promises and challenges of this approach.
-
Plenary session to discuss accessibility of gene therapy across the globe
Jennifer E. Adair, PhD, FUNAS, gives a preview of this session on the current landscape of gene therapy.
-
Meet the abstract presenter: Alfred Garfall, MD
Alfred Garfall, MD, will present one of the abstracts featured in the Late-Breaking Abstracts session on Saturday during the Tandem Meetings.
-
Meet the abstract presenter: Daniel Brown, PhD
Daniel Brown, PhD, will present one of the abstracts featured in the Late-Breaking Abstracts session on Saturday during the Tandem Meetings.